Gilead Sciences Inc
F:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
F:GIS
|
US |
|
Electronic Arts Inc
NASDAQ:EA
|
US |
|
UFP Technologies Inc
F:UFP
|
US |
|
H
|
Home Depot Inc
XMUN:HDI
|
US |
|
Ariana Resources PLC
F:4A6
|
UK |
|
GE Vernova Inc
F:Y5C
|
US |
|
Comer Industries SpA
MIL:COM
|
IT |
|
Olin Corp
NYSE:OLN
|
US |
|
ING Groep NV
F:INN1
|
NL |
|
Intercontinental Exchange Inc
NYSE:ICE
|
US |
|
T
|
Thonburi Healthcare Group PCL
SET:THG
|
TH |
|
Immunome Inc
NASDAQ:IMNM
|
US |
|
Natwest Group PLC
F:RYS
|
UK |
|
Chemometec A/S
F:CHY
|
DK |
|
S
|
Shell PLC
AEX:SHELL
|
UK |
|
Equifax Inc
NYSE:EFX
|
US |
|
Biprogy Inc
OTC:NTULF
|
JP |
|
S
|
Schneider Electric SE
XMUN:SND
|
FR |
|
I
|
IAMGOLD Corp
XMUN:IAL
|
CA |
|
S
|
Secom Co Ltd
DUS:XSC
|
JP |
|
S
|
Supernus Pharmaceuticals Inc
SWB:S49
|
US |
|
F
|
Fastenal Co
XHAM:FAS
|
US |
|
Hisamitsu Pharmaceutical Co Inc
OTC:HTSUY
|
JP |
|
S
|
Steel Dynamics Inc
XMUN:SD5
|
US |
Bankruptcy Probability
Gilead Sciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gilead Sciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
369.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
136.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
92.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Biogen Inc
NASDAQ:BIIB
|
32.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gilead Sciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gilead Sciences Inc has total debt of 23.8B USD. This includes both short-term (0 USD) and long-term (23.8B USD) debt.
You can find a full breakdown on its Balance Sheet.
